Authors/Disclosures
|
Adam Loavenbruck, MD
(University of Minnesota)
|
Dr. Loavenbruck has nothing to disclose. |
|
Vinay Chaudhry, MD, FAAN
|
Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. |
|
E M. Bebin, MD, FAAN
(UAB Epilepsy Center)
|
Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Christopher J. Klein, MD, FAAN
(Mayo Clinic)
|
Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. |